Oruka Therapeutics, Inc. (ORKA) Institutional Ownership

Ownership Summary

Oruka Therapeutics, Inc. (NASDAQ:ORKA) currently has 3 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 0.0% of the company's total shares outstanding in December 2025, down from 82.9% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 32215.38%, with a year-over-year a decrease of 95.45% in the count of filers.
• The latest 13F cycle for Oruka Therapeutics reveals that of 3 total investors, 2 funds grew their exposure, whereas 0 reduced theirs and 1 made no changes.
• Collectively, institutional investors increased their stake in Oruka Therapeutics to 8.40K shares as of December 2025, a change that is up by 8.38K shares quarter on quarter and down 30.93Mn shares year over year.
• With 8.28K shares, SG Americas Securities, LLC commands the largest institutional position in Oruka Therapeutics as of December 31, 2025, equating to 0.02% of the company.
• Among the most significant buyers of Oruka Therapeutics during December 2025 were SG Americas Securities, LLC (8.28K), GAMMA Investing LLC (101).
• The top 3 institutional holders of Oruka Therapeutics for the quarter ending December 2025 included SG Americas Securities, LLC (8.28K), GAMMA Investing LLC (101), True Wealth Design, LLC (26).